RGEN Financial Facts
Total operating expenses: 20.93MResearch and development: 1.89M
See Full Income Statement
Prepaid expenses and other current assets: 1.28M
Royalties receivable: 226K
See Full Balance Sheet
Repligen Corporation (RGEN) Earnings
|
Expand Research on RGEN
| Next EPS Date | 5/1/24 | EPS Growth Rate | -53.1% |
|---|---|---|---|
| Average EPS % Beat Rate | +15.7% | Revenue Growth Rate | -17.9% |
| Average % Move 1-Wk after EPS | +7.0% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3/16/12 | Q312 | -$0.07 | N/A | N/A | $7.17M | $7.07M |  |
 | | Details | |
6/9/11  |
 |
Q411 | -$0.06 | -$0.03 | -$0.03 | $5.9M | $6.2M | |
| | Details |
| 3/13/15 |
|
Q414 | -$0.01 | $0.04 | -$0.05 | $15.4M | $14.7M | N/A | | | Details |
| 5/1/24 |
Q124 | N/A | $0.30 | N/A | N/A | $150.06M |  |
N/A | N/A | ||
| 7/27/11 |
|
Q112 | $0.00 | -$0.01 | +$0.01 | $7.65M | $7.5M | |
| | Details |
| 2/9/11 |
|
Q311 | $0.01 | -$0.03 | +$0.04 | $7.09M | $6.1M | N/A | | | Details |
| 10/27/11 | |
Q212 | $0.02 | -$0.02 | +$0.04 | $8.63M | $7.5M | |
| | Details |
| 5/3/12 |
|
Q112 | $0.04 | N/A | N/A | $12.84M | $7M | |
| | Details |
